Percutaneous ablation of perforator veins in patients with lower extremity varicose veins combined with incompetent perforator veins: analysis of 36 cases

doi:10.3877/cma.j.issn.2095-5782.2021.04.002

Abstract

Abstract:

Objective

To evaluate the clinical effect of percutaneous ablation of perforator veins(PAPS) in patients with lower extremity varicose veins combined with incompetent perforator veins(IPVs).

Methods

Clinical data of 36 patients who were diagnosed as lower extremity varicose veins with IPVs manifested by imaging examination,and treated by PAPS were collected and reviewed retrospectively. Patients were followed up 1 month and 3 months after discharge to analyze the therapeutic effect, complications and recurrence.

Results

47 limbs were performed PAPS in 36 patients. The technical success rate was 100%. The venous clinical severity score (VCSS) and the chronic venous insufficiency questionnaire (CIVIQ) at 1 month and 3 months after surgery were improved compared with the pre-operation. Some patients experienced mild complications such as pain, phlebitis, scleroma and paresthesia after treatment. No recurrence was found in 3 months follow-up.

Conclusions

For patients with varicose vein combined with IPVs, the PAPS can achieve good clinical results.

Key words: Lower extremity varicose vein, Incompetent perforator veins, Percutaneous ablation of perforator veins

Jianan He, Yongyu Zhang, Dashuai Wang, Ni Zhao, Weile Huang, Hui Guo. Percutaneous ablation of perforator veins in patients with lower extremity varicose veins combined with incompetent perforator veins: analysis of 36 cases[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2021, 09(04): 360-364.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2021.04.002

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2021/V09/I04/360

Figures/Tables 4

References 28

[1]	刘凯，马韧石，王蕾, 等. 下肢静脉曲张微创治疗的研究进展[J]. 血管与腔内血管外科杂志, 2016, 2(2): 166-170.
[2]	Melikian R, O'Donnell TJ, Suarez L, et al. Risk factors associated with the venous leg ulcer that fails to heal after 1 year of treatment[J]. J Vasc Surg Venous Lymphat Disord, 2019, 7(1): 98-105.
[3]	冯惠岗，张健谊，梁奇伟, 等. 聚多卡醇与鱼肝油酸钠泡沫硬化治疗下肢静脉曲张的疗效差异[J]. 中华介入放射学电子杂志, 2021, 9(3): 270-274.
[4]	Pierik EG, Toonder IM, van Urk H, et al. Validation of duplex ultrasonography in detecting competent and incompetent perforating veins in patients with venous ulceration of the lower leg[J]. J Vasc Surg, 1997, 26(1): 49-52.
[5]	Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum[J]. J Vasc Surg, 2011, 53(5 Suppl): 2S-48S.
[6]	黄晨，郑晓兵. 复发性下肢静脉曲张的治疗[J]. 中国血管外科杂志(电子版), 2018, 10(2): 117-119.
[7]	Kuyumcu G, Salazar GM, Prabhakar AM, et al. Minimally invasive treatments for perforator vein insufficiency[J]. Cardiovasc Diagn Ther, 2016, 6(6): 593-598.
[8]	Yang L, Wang X, Wei Z, et al. The clinical outcomes of endovenous microwave and laser ablation for varicose veins:a prospective study[J]. Surgery, 2020, 168(5): 909-914.
[9]	Aurshina A, Ascher E, Mount L, et al. Success rate and factors predictive of redo radiofrequency ablation of perforator veins[J].J Vasc Surg Venous Lymphat Disord, 2018, 6(5): 621-625.
[10]	刚清伟，王成刚，吴丹明, 等. 电凝术治疗下肢静脉曲张并发症的预防及处理[J]. 中国血管外科杂志(电子版), 2019, 11(2): 90-92, 96.
[11]	Zollmann M, Zollmann C, Zollmann P, et al. Recurrence types 3 years after endovenous thermal ablation in insufficient saphenofemoral junctions[J]. J Vasc Surg Venous Lymphat Disord, 2021, 9(1): 137-145.
[12]	Marston WA, Crowner J, Kouri A, et al. Incidence of venous leg ulcer healing and recurrence after treatment with endovenous laser ablation[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(4): 525-532.
[13]	Woźniak W, Mlosek RK, Ciostek P. Complications and failure of endovenous laser ablation and radiofrequency ablation procedures in patients with lower extremity Varicose veins in a 5-year follow-up[J]. Vasc Endovascular Surg, 2016, 50(7): 475-483.
[14]	Lawaetz M, Serup J, Lawaetz B, et al. Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins extended 5-year follow-up ofa RCT[J]. Int Angiol, 2017, 36(3): 281-288.
[15]	García-Gimeno M, Rodríguez-Camarero S, Tagarro-Villalba S, et al. Duplex mapping of 2036 primary varicose veins[J]. J Vasc Surg, 2009, 49(3): 681-689.
[16]	Chastanet S, Pittaluga P. Patterns of reflux in the great saphenous vein system[J]. Phlebology, 2013, 28(Suppl 1): 39-46.
[17]	Stuart WP, Adam DJ, Allan PL, et al. The relationship between the number, competence, and diameter of medial calf perforating veins and the clinical status in healthy subjects and patients with lower-limb venous disease[J]. J Vasc Surg, 2000, 32(1): 138-143.
[18]	Pitoulias AG, Chatzelas D, Kalogirou TE, et al. Ultrasonographic hemodynamical and epidemiological factors in advancement of clinical manifestations in primary varicose veins[J]. Int Angiol, 2021, 40(5): 359-367.
[19]	Kusagawa H. Surgery for varicose veins caused by atypical incompetent perforating veins[J]. Ann Vasc Dis, 2019, 12(4): 443-448.
[20]	马芳，许继梅，刘咸罗. 彩色多普勒超声对下肢交通支静脉功能不全的诊疗价值[J]. 中国超声医学杂志, 2018, 34(4): 346-349.
[21]	Bergan JJ. The vein book. Chapter 5: role of physiologic testing in venous disorders[M]. London:Elsevier, 2007: 50.
[22]	Onida S, Davies AH. CHIVA, ASVAL and related techniques—concepts and evidence[J]. Phlebology, 2015, 30(2 Suppl): 42-45.
[23]	Rueda CA, Bittenbinder EN, Buckley CJ, et al. The management of chronic venous insufficiency with ulceration: the role of minimally invasive perforator interruption[J]. Ann Vasc Surg, 2013, 27(1): 89-95.
[24]	Hamann S, Timmer-De ML, Fritschy WM, et al. Randomized clinical trial of endovenous laser ablation versus direct and indirect radiofrequency ablation for the treatment of great saphenous varicose veins[J]. Br J Surg, 2019, 106(8): 998-1004.
[25]	Lawrence PF, Alktaifi A, Rigberg D, et al. Endovenous ablation of incompetent perforating veins is effective treatment for recalcitrant venous ulcers[J]. J Vasc Surg, 2011, 54(3): 737-742.
[26]	Dillavou ED, Harlander-Locke M, Labropoulos N, et al. Current state of the treatment of perforating veins[J]. J Vasc Surg Venous Lymphat Disord, 2016, 4(1): 131-135.
[27]	Wang CM, Zhao SL, Feng QC, et al. One-year outcomes of radiofrequency ablation of incompetent perforator veins using the radiofrequency stylet device: Cohort study from East Asia[J]. Phlebology, 2021, 36(4): 268-274.
[28]	王海涛，迟德财，宗亚光, 等. 病理性穿通静脉电凝术治疗重度慢性下肢静脉功能不全的临床观察[J]. 心肺血管病杂志, 2020, 39(5): 594-596.

项目		±s或n（%）
性别
	男	18（50%）
	女	18（50%）
年龄（岁）		53.83 ± 10.45
病程（年）		13.75 ± 10.96
患肢
	双侧	11（30.56%）
	左侧	15（41.67%）
	右侧	10（27.77%）
穿通静脉解剖定位
	Dodd组穿通支	3（6.12%）
	Boyd组穿通支	1（2.04%）
	Cockett组穿通支	45（91.84%）
术前CEAP分级
	C2级	3（8.33%）
	C3级	4（11.12%）
	C4级	14（38.89%）
	C5级	12（33.33%）
	C6级	3（8.33%）
治疗方式
	腔内消融	23（63.89%）
	腔内电凝	13（36.11%）

项目		±s或n（%）
性别
	男	18（50%）
	女	18（50%）
年龄（岁）		53.83 ± 10.45
病程（年）		13.75 ± 10.96
患肢
	双侧	11（30.56%）
	左侧	15（41.67%）
	右侧	10（27.77%）
穿通静脉解剖定位
	Dodd组穿通支	3（6.12%）
	Boyd组穿通支	1（2.04%）
	Cockett组穿通支	45（91.84%）
术前CEAP分级
	C2级	3（8.33%）
	C3级	4（11.12%）
	C4级	14（38.89%）
	C5级	12（33.33%）
	C6级	3（8.33%）
治疗方式
	腔内消融	23（63.89%）
	腔内电凝	13（36.11%）

组别	VCSS			CIVIQ
组别	±s	t值	P值	±s	t值	P值
术前	10 ± 4.67	-	-	55.67 ± 7.73	-	-
术后1个月	7.64 ± 4.03	5.34	< 0.01	60.14 ± 6.95	-5.00	< 0.01
术后3个月	4.36 ± 2.24	9.67	< 0.01	64.92 ± 3.89	-10.217	< 0.01

组别	VCSS			CIVIQ
组别	±s	t值	P值	±s	t值	P值
术前	10 ± 4.67	-	-	55.67 ± 7.73	-	-
术后1个月	7.64 ± 4.03	5.34	< 0.01	60.14 ± 6.95	-5.00	< 0.01
术后3个月	4.36 ± 2.24	9.67	< 0.01	64.92 ± 3.89	-10.217	< 0.01

组别	VCSS			CIVIQ
组别	术前	术后1个月	术后3个月	术前	术后1个月	术后3个月
腔内消融	10.78 ± 4.42	8.04 ± 3.76	4.61 ± 1.99	55.04 ± 8.75	59.7 ± 7.93	64.57 ± 4.28
腔内电凝	8.62 ± 4.96	6.92 ± 4.54	3.92 ± 2.66	56.77 ± 5.64	60.92 ± 4.94	65.54 ± 3.13
t值	1.353	0.797	0.877	-0.638	-0.504	-0.717
P值	0.185	0.431	0.386	0.528	0.618	0.479

Please choose a citation manager

Content to export